SEARCH

SEARCH BY CITATION

References

  • 1
    Beishuizen, A., Verhoeven, M.A., Hahlen, K., Van Wering, E.R., Van Dongen, J.J. (1993) Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leukemia at diagnosis. Leukemia, 7, 60 63.
  • 2
    Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., Sultan, C. (1976) Proposals for the classification of the acute leukaemias. French–American–British (FAB) co-operative group. British Journal of Haematology, 33, 451 458.
  • 3
    Brisco, M.J., Condon, J., Hughes, E., Neoh, S.H., Sykes, P.J., Seshadri, R., Toogood, I., Waters, K., Tauro, G., Ekert, H., Morley, A.A. (1994) Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet, 343, 196 200.
  • 4
    Campana, D., Coustan-Smith, E., Janossy, G. (1990) Immunophenotyping in haematological diagnosis. Baillieres Clinical Haematology, 3, 889 919.
  • 5
    Cavé, H., Guidal, C., Rohrlich, P., Delfau, M.H., Broyart, A., Lescoeur, B., Rahimy, C., Fenneteau, O., Monplaisir, N., D'auriol, L., Elion, J., Vilmer, E., Grandchamp, B. (1994) Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. Blood, 83, 1892 1902.
  • 6
    Chessells, J.M., Bailey, C., Richards, S.M. (1995) Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet, 345, 143 148.
  • 7
    Evans, P.A.S., Short, M.A., Owen, R.G., Mistry, D., Shiach, C.R., Kinsey, S., Davies, F.E., Jack, A.S., Morgan, G.J. (1997) A clinical evaluation of fluorescent consensus immunoglobulin heavy chain PCR for the monitoring of residual disease in paediatric acute lymphoblastic leukaemia. (Abstract). British Journal of Haematology, 97, 11.
  • 8
    Goulden, N., Langlands, K., Steward, C., Katz, F., Potter, M., Chessells, J., Oakhill, A. (1994) PCR assessment of bone marrow status in ‘isolated’ extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia. British Journal of Haematology, 87, 282 285.
  • 9
    Knechtli, C.J.C., Goulden, N.J., Langlands, K., Potter, M.N. (1995) The study of minimal residual disease in acute lymphoblastic leukaemia. Journal of Clinical Pathology: Clinical Molecular Pathology, 48, M65 M73.
  • 10
    Kwok, S. & Higuchi, R. (1989) Avoiding false positives with PCR. Nature, 339, 237 238.
  • 11
    Langlands, K., Goulden, N.J., Steward, C.G., Potter, M.N., Cornish, J.M., Pamphilon, D.H., Oakhill, A. (1994) False-positive residual disease assessment after bone marrow transplant in acute lymphoblastic leukemia. Blood, 84, 1352 1353.
  • 12
    Langlands, K., Goulden, N.J., Steward, C.G., Potter, M.N., Oakhill, A. (1995) Solid-phase sequencing of multiple PCR products resolved by polyacrylamide gel electrophoresis. Biotechniques, 18, 618 620.
  • 13
    Lilleyman, J.S., Gibson, B.E.S., Stevens, R.F., Will, A.M., Hann, I.M., Richard, P., Richards, S.M., Hill, F.G.H. (1997) Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. British Journal of Haematology, 97, 603 606.
  • 14
    Martens, A.C.M., Schultz, F.W., Hagenbeek, A. (1987) Non-homogeneous distribution of leukemia in the bone marrow during minimal residual disease. Blood, 70, 1073 1076.
  • 15
    Neale, G.A.M., Pui, C.H., Mahmoud, H.H., Mirro, J., Jr , Crist, W.M., Rivera, G.K., Goorha, R.M. (1994) Molecular evidence for minimal residual bone marrow disease in children with ‘isolated’ extramedullary relapse of T-cell acute lymphoblastic leukemia. Leukemia, 8, 768 775.
  • 16
    O'reilly, J., Meyer, B., Baker, D., Herrmann, R., Cannell, P., Davies, J. (1995) Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukemia. Leukemia, 9, 624 627.
  • 17
    Ouspenskaia, M.V., Johnston, D.A., Roberts, W.M., Estrov, Z., Zipf, T.F. (1995) Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved. Leukemia, 9, 321 328.
  • 18
    Owen, R.G., Goulden, N.J., Oakhill, A., Shiach, C., Evans, P.A., Potter, M.N., Morgan, G.J. (1997) Comparison of fluorescent consensus IgH PCR and allele-specific oligonucleotide probing in the detection of minimal residual disease in childhood ALL. British Journal of Haematology, 97, 457 459.
  • 19
    Potter, M.N., Steward, C.G., Oakhill, A. (1993) The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia. British Journal of Haematology, 83, 412 418.
  • 20
    Pui, C.H. (1995) Childhood leukemias. New England Journal of Medicine, 332, 1618 1627.
  • 21
    Roberts, W.M., Estrov, Z., Kitchingman, G.R., Zipf, T.F. (1996) The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification by antigen-receptor gene sequences. Leukemia and Lymphoma, 20, 181 197.
  • 22
    Roberts, W.M., Estrov, Z., Ouspenskaia, M.V., Johnston, D.A., McClain, K.L., Zipf, T.F. (1997) Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. New England Journal of Medicine, 336, 317 323.
  • 23
    Sambrook, J., Fritsch, E.F., Maniatis, T. (1989) Commonly used techniques in molecular cloning. Molecular Cloning: a Laboratory Manual, 2nd edn, appendix E, page E.3. Cold Spring Harbor Laboratory Press, New York.
  • 24
    Seriu, T., Dieter-Ludwig, W., Schrappe, M., Erz, D., Stark, Y., Bartram, C.R. (1997) Prospective monitoring of minimal residual disease in childhood acute lymphoblastic leukemia enrolled in German BFM study. (Abstract). Annals of Hematology, 74, (Suppl. I), A53.
  • 25
    Steenbergen, E.J., Verhagen, O.J., Van Leeuwen, E.F., Van Den Berg, H., Behrendt, H., Slater, R.M., Von Dem Borne, A.E., Van Der Schoot, C.E. (1995) Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia. Leukemia, 9, 1726 1734.
  • 26
    Steenbergen, E.J., Verhagen, O.J., Van Leeuwen, E.F., Von Dem Borne, A.E., Van Der Schoot, C.E. (1993) Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia. Blood, 82, 581 589.
  • 27
    Steinherz, P.G., Gaynon, P.S., Breneman, J.C., Cherlow, J.M., Grossman, N.J., Kersey, J.H., Johnstone, H.S., Sather, H.N., Trigg, M.E., Chappell, R., Hammond, D., Bleyer W.A., (1996) Cytoreduction and prognosis in acute lymphoblastic leukemia: the importance of early marrow response: report from the Childrens Cancer Group. Journal of Clinical Oncology, 14, 389 398.
  • 28
    Steward, C.G., Goulden, N.J., Katz, F., Baines, D., Martin, P.G., Langlands, K., Potter, M.N., Chessells, J.M., Oakhill, A. (1994) A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood, 83, 1355 1362.